Targeting platelet GPVI with glenzocimab: a novel mechanism for inhibition.
Billiald P, Slater A, Welin M, Clark JC, Loyau S, Pugnière M, Jiacomini IG, Rose N, Lebozec K, Toledano E, François D, Watson SP, Jandrot-Perrus M.
Billiald P, et al.
Blood Adv. 2023 Apr 11;7(7):1258-1268. doi: 10.1182/bloodadvances.2022007863.
Blood Adv. 2023.
PMID: 36375047
Free PMC article.